News
What's happening in Alzheimer's care, research funding, and treatment — summarized simply, each item linked to the original reporting.
Free to read, “May need a subscription” and “Archived copy”: what they mean
Whether an article is free to read is a guess, not a test of your access. Each item is one of three:
- No label: free to read (303 of 347). The publisher’s page marks it free, or the outlet publishes free to read: Medical Xpress, ScienceDaily, NIH (incl. NIA and PMC), Alzheimer's Association, Alzheimer's News Today, NPR, Alzheimer's Disease International, or a .gov site.
- May need a subscription (11 of 347). The publisher’s own page marks the article as not free to read, or — when the page says nothing — the outlet sells subscriptions: The New York Times, STAT, Scientific American, The Washington Post, The Wall Street Journal, Financial Times, The Economist, Bloomberg, The Atlantic, The New Yorker, Wired, Los Angeles Times, The Boston Globe, The Times, The Telegraph, New Scientist, Endpoints News, Science. Each badge says which.
- “Free to read? Not known” (33 of 347). The outlet is on neither list and its page said nothing. We do not call these paywalled.
Archived copy links go to a copy the Internet Archive (web.archive.org) saved, dated the day it was saved. We show one only where the Internet Archive reported a working saved copy when we checked; an archived copy of a subscription article sometimes shows only its opening. 265 of 347 items have one.
Treatment revives old liver cells in lab study, may help prevent Alzheimer's and heart disease
The liver's job of clearing harmful substances from the body is so essential that the organ may have implications for addressing unexpected diseases, including Alzheimer's and heart disease. …
Read at Medical Xpress →Tuberculosis vaccine's link to reduced dementia risk gains mechanistic support
Bacillus Calmette-Guerin (BCG), a vaccine widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia, according to new findings in a study of mice. …
Read at Medical Xpress →Brain-protective molecule may help preserve memory during aging
As humans age, both protective and harmful biological processes shape brain health. When the balance shifts in favor of harmful processes, age-related changes in the brain can accelerate, including synapse loss, disruptions in lipid metabolism and chronic inflammation.
Read at Medical Xpress → Archived copy (18 Oct 2026), Internet ArchiveIncreasing protective protein suppresses Parkinson's-linked buildup, more than doubling lifespan in mouse model
Parkinson's disease is the second most common neurodegenerative disease. Over the last 30 years, studies have shown that a protein called alpha-synuclein abnormally aggregates in people with Parkinson's disease…
Read at Medical Xpress → Archived copy (13 Oct 2026), Internet ArchiveObesity's link to lower risk of death in dementia points to likely importance of nutrition
People who are overweight or obese when they are diagnosed with dementia are likely to live longer than those in a normal weight range, according to a new study by Columbia University Mailman School of Public Health and NYU School of Global Public Health. …
Read at Medical Xpress → Archived copy (7 Oct 2026), Internet ArchiveWhy hearing loss deserves earlier attention in dementia prevention
Dr. Brent Tipping, a geriatrician at Wits Donald Gordon Medical Center (WDGMC), says that hearing loss more than doubles the odds of dementia, with visual impairment (both near and far) also elevating the risk.
Managing misfolded proteins to prevent Parkinson's disease
The protein alpha-synuclein is abundant in healthy brains and plays an important role in enabling communication between nerve cells. However, under certain conditions, misfolded alpha-synuclein proteins can accumulate into toxic clumps inside neurons. …
Read at Medical Xpress →Hearing aids show promise for cognitive recovery, but dementia prevention remains unproven
People who live long enough have a high chance of losing some of their hearing as they grow older. By age 60, about one in three adults has presbycusis, an age-related decline in hearing caused by changes inside the ear…
Why it matters: Hearing aids show potential for helping cognitive recovery, though their ability to prevent dementia is still unproven.
Read at Medical Xpress → Archived copy (2 Oct 2026), Internet ArchiveGenetic analysis reveals potential benefit of aspirin for reducing dementia risk
Low-dose aspirin was associated with a 70% lower risk of dementia among older people with a particular genetic profile, a new Monash University analysis has found, raising the possibility of a more personalized approach to dementia prevention.
Read at Medical Xpress →Can hormone replacement therapy prevent dementia? What the latest research tells us
A study has raised a question that many women would understandably want answered: Could hormone replacement therapy (HRT) protect against dementia? …
Why it matters: A study raised a key question about whether hormone replacement therapy (HRT) could help protect women against dementia.
Read at Medical Xpress →Tubulin prevents toxic brain protein clumps linked to Alzheimer’s and Parkinson’s
Scientists at Baylor College of Medicine may have uncovered a promising new way to combat Alzheimer’s and Parkinson’s disease. Instead of trying to stop Tau and alpha-synuclein proteins from gathering into tiny droplets inside brain cells, the researchers found that tubulin…
Read at ScienceDaily → Archived copy (22 Jun 2026), Internet ArchiveShingles vaccination associated with delayed dementia onset in older adults
Every three seconds, someone, somewhere in the world, develops dementia. The number of people living with the condition is projected to rise dramatically, doubling from 78 million in 2020 to 139 million by 2050, making dementia an urgent public health concern of our time. …
Why it matters: Dementia is an urgent public health concern with cases projected to double from 78 million in 2020 to 139 million by 2050, as someone develops it every three seconds.
Brain 'hazmat' protein cleans up tau: Could it prevent dementia?
Researchers at UC San Francisco have identified a hazardous waste collector in the brain that disposes of the toxic clumps of tau protein that can lead to dementia. Neurons with more of this garbage collector, technically known as CUL5, are less vulnerable to Alzheimer's disease.
Why it matters: UC San Francisco researchers found that neurons with more CUL5, a brain waste collector, are less vulnerable to Alzheimer's disease.
Nitrate in drinking water linked to increased dementia risk while nitrate from vegetables is linked to a lower risk
New research from Edith Cowan University (ECU) and the Danish Cancer Research Institute (DCRI) investigated the association between the intake of nitrate and nitrite from a wide range of different sources, and the associated risk of dementia.
Why it matters: New ECU and DCRI research links nitrate intake from drinking water to higher dementia risk, while vegetable nitrate is linked to lower risk.
Read at Medical Xpress → Archived copy (27 Jan 2026), Internet ArchiveGenetic risk combined with cardiovascular factors may help predict and delay dementia
Combining genetic risk with cardiovascular disease risk factors—such as high LDL cholesterol, obesity, and hypertension—may predict who is more likely to develop dementia, according to a new study led by UC San Francisco.
Why it matters: Combining genetic risk with cardiovascular disease risk factors—such as high LDL cholesterol, obesity, and hypertension—may predict who is more likely to develop dementia.
Read at Medical Xpress → Archived copy (22 Jan 2026), Internet ArchiveShingles vaccine most promising common drug to potentially prevent Alzheimer's
A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.
Why it matters: A new study identified three existing medications, including the shingles vaccine, that could be repurposed to treat or prevent Alzheimer's disease.
Read at Medical Xpress → Archived copy (19 Nov 2025), Internet ArchiveProtective microglia subtype offers potential therapeutic pathway in Alzheimer's disease
In Alzheimer's disease—the leading cause of dementia—microglia, the brain's immune defenders, can act as both protectors and aggressors, shaping how the disease progresses.
Read at Medical Xpress → Archived copy (15 Nov 2025), Internet ArchiveNIA-funded small business spotlight: Bone Health Technologies shakes up the market to prevent bone density loss
Read how Bone Health Technologies, an NIA-funded small business, shakes up the market to prevent bone density loss.
Why it matters: Bone Health Technologies, an NIA-funded small business, is shaking up the market to prevent bone density loss.
Read at NIH National Institute on Aging → Archived copy (12 Jul 2025), Internet ArchiveFollow new items in a feed reader: Atom feed.